Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/ MAPK Pathway of Hepatic Stellate Cells.
Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/ MAPK Pathway of Hepatic Stellate Cells.
复制标题
DOI：
10.4062/biomolther.2020.016
复制
发表时间：
2020-11-01
影响因子：
3.7
通讯作者：
Hong SS
中科院分区：
文献类型：
--
作者：
Yoon YC;Fang Z;Lee JE;Park JH;Ryu JK;Jung KH;Hong SS
Liver fibrosis constitutes a significant health problem worldwide due to its rapidly increasing prevalence and the absence of specific and effective treatments. Growing evidence suggests that apoptosis-signal regulating kinase 1 (ASK1) is activated in oxidative stress, which causes hepatic inflammation and apoptosis, leading to liver fibrogenesis through a mitogen-activated protein kinase (MAPK) downstream signals. In this study, we investigated whether selonsertib, a selective inhibitor of ASK1, shows therapeutic efficacy for liver fibrosis, and elucidated its mechanism of action in vivo and in vitro. As a result, selonsertib strongly suppressed the growth and proliferation of hepatic stellate cells (HSCs) and induced apoptosis by increasing Annexin V and TUNEL-positive cells. We also observed that selonsertib inhibited the ASK1/MAPK pathway, including p38 and c-Jun N-terminal kinase (JNK) in HSCs. Interestingly, dimethylnitrosamine (DMN)-induced liver fibrosis was significantly alleviated by selonsertib treatment in rats. Furthermore, selonsertib reduced collagen deposition and the expression of extracellular components such as α-smooth muscle actin (α-SMA), fibronectin, and collagen type I in vitro and in vivo. Taken together, selonsertib suppressed fibrotic response such as HSC proliferation and extracellular matrix components by blocking the ASK1/MAPK pathway. Therefore, we suggest that selonsertib may be an effective therapeutic drug for ameliorating liver fibrosis.
登录
查看更多内容
DOI：
10.1164/rccm.201703-0502oc
发表时间：
2018-02-01
影响因子：
24.7
作者：
Budas, Grant R.;Boehm, Mario;Schermuly, Ralph T.
通讯作者：
Schermuly, Ralph T.
影响因子：
16.1
作者：
Higashi T;Friedman SL;Hoshida Y
通讯作者：
Hoshida Y
影响因子：
15.9
作者：
Liles, John T.;Corkey, Britton K.;Breckenridge, David G.
通讯作者：
Breckenridge, David G.
影响因子：
29.4
作者：
Ikejima, K;Takei, Y;Sato, N
通讯作者：
Sato, N
影响因子：
29.4
作者：
Kluwe J;Pradere JP;Gwak GY;Mencin A;De Minicis S;Osterreicher CH;Colmenero J;Bataller R;Schwabe RF
通讯作者：
Schwabe RF